Search hospitals > Florida > Fort Myers
National Ophthalmic Research Institute
Claim this profileFort Myers, Florida 33912
Global Leader in Age-Related Macular Degeneration
Global Leader in Diabetic Macular Edema
Conducts research for Macular Degeneration
Conducts research for Diabetic Retinopathy
Conducts research for None
46 reported clinical trials
4 medical researchers
Summary
National Ophthalmic Research Institute is a medical facility located in Fort Myers, Florida. This center is recognized for care of Age-Related Macular Degeneration, Diabetic Macular Edema, Macular Degeneration, Diabetic Retinopathy, None and other specialties. National Ophthalmic Research Institute is involved with conducting 46 clinical trials across 26 conditions. There are 4 research doctors associated with this hospital, such as A. T. Ghuman, MD, Ashish Sharma, MD, Katrina Mears, MD, and Avtar T Ghuman, MD.Top PIs
A. T. Ghuman, MDNational Ophthalmic Research Institute2 years of reported clinical research
Studies Diabetic Macular Edema
Studies Macular Degeneration
2 reported clinical trials
3 drugs studied
Ashish Sharma, MDNational Ophthalmic Research Institute2 years of reported clinical research
Studies Age-Related Macular Degeneration
1 reported clinical trial
1 drug studied
Katrina Mears, MDNational Ophthalmic Research Institute2 years of reported clinical research
Studies Diabetic Retinopathy
Studies Diabetic Macular Edema
1 reported clinical trial
2 drugs studied
Avtar T Ghuman, MDNational Ophthalmic Research Institute4 years of reported clinical research
Studies Diabetic Retinopathy
1 reported clinical trial
2 drugs studied
Clinical Trials running at National Ophthalmic Research Institute
Age-Related Macular Degeneration
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy
Choroidal Neovascularization
Retinal Degeneration
Retinal Disease
None
Choroidal neovascularization
Wet AMD
RGX-314 Gene Therapy
for Age-Related Macular Degeneration
This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.
Recruiting2 awards Phase 32 criteria
PDS Implant with Ranibizumab
for Age-Related Macular Degeneration
This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.
Recruiting2 awards Phase 33 criteria
Pozelimab + Cemdisiran
for Macular Degeneration
This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atrophy (GA) caused by Age-related Macular Degeneration (AMD). Geographic atrophy is a medical term that refers to later-stage cases of AMD which is an eye condition affecting central vision (what one sees straight ahead). The purpose of this study is to evaluate the progression rate of Geographic Atrophy in eyes of patients treated with cemdisiran alone or in combination with pozelimab compared to those treated with placebo. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug(s) * How much study drug(s) are in the blood at different times * Whether the body makes antibodies against the study drug(s) (which could make the study drug(s) less effective or could lead to side effects)
Recruiting1 award Phase 33 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at National Ophthalmic Research Institute?
National Ophthalmic Research Institute is a medical facility located in Fort Myers, Florida. This center is recognized for care of Age-Related Macular Degeneration, Diabetic Macular Edema, Macular Degeneration, Diabetic Retinopathy, None and other specialties. National Ophthalmic Research Institute is involved with conducting 46 clinical trials across 26 conditions. There are 4 research doctors associated with this hospital, such as A. T. Ghuman, MD, Ashish Sharma, MD, Katrina Mears, MD, and Avtar T Ghuman, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.